PRN: Global Viral Conjunctivitis Drugs Market to Grow 2.41% (2016-2020) - Increased Use of Off-Label Drugs

Global Viral Conjunctivitis Drugs Market to Grow 2.41% (2016-2020) - Increased Use of Off-Label Drugs [23-March-2016] DUBLIN, March 23, 2016 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/nwf6wt/global_viral) has announced the addition of the "Global Viral Conjunctivitis Drugs Market 2016-2020" report to their offering.

Persone Laura Wood, Topics Covered
Luoghi Dublino, Stati Uniti d'America
Organizzazioni Hours, Pharma Rapid Pathogen Screening Shire Starpharma Valeant Pharmaceuticals, Global Viral Conjunctivitis Drugs Market, FDA
Argomenti software, commercio, internet, economia

23/mar/2016 17:10:13 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Viral Conjunctivitis Drugs Market to Grow 2.41% (2016-2020) - Increased Use of Off-Label Drugs

 
[23-March-2016]
 

DUBLIN, March 23, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/nwf6wt/global_viral) has announced the addition of the "Global Viral Conjunctivitis Drugs Market 2016-2020" report to their offering.

The global viral conjunctivitis drugs market is expected to grow at a CAGR of 2.41% during the period 2016-2020.

The unavailability of approved drugs for the treatment of diseases results in increased use of off-label drugs. These drugs are available at lower prices. Topical NSAIDs and lubricants are used as off-label treatments for ophthalmic indications. Though the safety profiles of these drugs are not determined by the US Food and Drug Administration (FDA), they are available in the market for a number of indications.

According to the report, awareness programs and campaigns by organizations in public and private sectors to help individuals understand how to treat and control the spread of the viral conjunctivitis infection will result in more people opting for treatment.

Further, the report states that the diagnosis rates of viral conjunctivitis are observed to be low, as most people prefer to allow the condition to heal on its own. Misdiagnosis also leads to the low diagnosis rate.

Key questions answered in this report:

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Companies Mentioned:

  • Akorn
  • Alcon
  • Allergan
  • Bausch & Lomb
  • Adenovir Pharma
  • Marinomed Biotechnologie
  • Mediolanum Laboratoires
  • NanoViricides
  • Nicox
  • Novartis
  • Panoptes Pharma
  • Rapid Pathogen Screening
  • Shire
  • Starpharma
  • Valeant Pharmaceuticals.

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Disease overview

PART 06: Pipeline analysis

PART 07: Market landscape

PART 08: Market segmentation by route of administration

PART 09: Geographical segmentation

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

For more information visit http://www.researchandmarkets.com/research/nwf6wt/global_viral

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl